KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Change in Accured Expenses: 2009-2019

Historic Change in Accured Expenses for Thermo Fisher Scientific (TMO) over the last 10 years, with Dec 2019 value amounting to $38.0 million.

  • Thermo Fisher Scientific's Change in Accured Expenses fell 75.80% to $38.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was $210.0 million, marking a year-over-year increase of 600.00%. This contributed to the annual value of $210.0 million for FY2019, which is 600.00% up from last year.
  • Per Thermo Fisher Scientific's latest filing, its Change in Accured Expenses stood at $38.0 million for Q4 2019, which was up 125.85% from -$147.0 million recorded in Q3 2019.
  • Thermo Fisher Scientific's Change in Accured Expenses' 5-year high stood at $992.0 million during Q4 2017, with a 5-year trough of -$471.0 million in Q1 2018.
  • For the 3-year period, Thermo Fisher Scientific's Change in Accured Expenses averaged around $98.7 million, with its median value being $127.0 million (2017).
  • Within the past 5 years, the most significant YoY rise in Thermo Fisher Scientific's Change in Accured Expenses was 12,019.44% (2015), while the steepest drop was 247.98% (2015).
  • Thermo Fisher Scientific's Change in Accured Expenses (Quarterly) stood at $436.3 million in 2015, then fell by 16.89% to $362.6 million in 2016, then soared by 173.58% to $992.0 million in 2017, then tumbled by 84.17% to $157.0 million in 2018, then plummeted by 75.80% to $38.0 million in 2019.
  • Its Change in Accured Expenses was $38.0 million in Q4 2019, compared to -$147.0 million in Q3 2019 and $549.0 million in Q2 2019.